Effect of CYP3A4*18B polymorphisms and interactions with OPRM1 A118G on postoperative fentanyl requirements in patients undergoing radical gastrectomy

Molecular Medicine Reports

Volumn 7, Issue 3, 2013, Pages 901-908

  Liao, Qin ^a   Chen, Dao Jin ^b   Zhang, Fan ^a   Li, Li ^a   Hu, Rong ^a   Tang, Yong Zhong ^a   Ou Yang, Wen ^a   Huang, Dong ^a  

^a Department of Anesthesiology ^*  (China)

^b THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

opioid receptor; Analgesia; Cytochrome P450 3A4; Fentanyl; Single nucleotide polymorphism

Indexed keywords

CYTOCHROME P450 3A4; ETOMIDATE; FENTANYL; MIDAZOLAM; MU OPIATE RECEPTOR; VECURONIUM; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A; NARCOTIC ANALGESIC AGENT; OPRM1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHINESE; CONTROLLED STUDY; DIZZINESS; DRUG SAFETY; DRUG USE; FEMALE; GASTRECTOMY; GENE FREQUENCY; GENE INTERACTION; GENERAL ANESTHESIA; GENOTYPE; HEREDITY; HETEROZYGOTE; HUMAN; INTRAVENOUS ANESTHESIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRURITUS; RESPIRATION DEPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SURGICAL PATIENT; VENOUS BLOOD; VOMITING; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PAIN ASSESSMENT; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; TIME; PAIN MEASUREMENT;

ADULT; AGED; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; CYTOCHROME P-450 CYP3A; DIZZINESS; FEMALE; FENTANYL; GASTRECTOMY; GENE FREQUENCY; GENOTYPE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PAIN MEASUREMENT; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; RECEPTORS, OPIOID, MU; TIME FACTORS; VOMITING;

EID: 84873157986     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1270     Document Type: Article

References (25)

1. Ikeda K, Ide S, Han W, Hayashida M, Uhl GR and Sora I: How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol Sci 26:311-317, 2005. (Pubitemid 40733524)
2. Evans WE and McLeod HL: Pharmacogenomics-drug disposition, drug targets and side effects. N Engl J Med 348:538-549, 2003. (Pubitemid 36159890)
3. Weinshilboum R: Inheritance and drug response. N Engl J Med 348:529-537, 2003. (Pubitemid 36159889)
4. Hu YF, Qiu W, Liu ZQ, et al: Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation. Clin Exp Pharmacol Physiol 33:1093-1098, 2006. (Pubitemid 44581573)
5. Feierman DE and Lasker JM: Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Drug Metab Dispos 24:932-939, 1996. (Pubitemid 26314543)
6. Tateishi T, Krivoruk Y, Ueng YF, Wood AJ, Guengerich FP and Wood M: Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation. Anesth Analg 82:167-172, 1996. (Pubitemid 26017401)
7. Labroo RB, Paine MF, Thummel KE and Kharasch ED: Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy and drug interactions. Drug Metab Dispos 25:1072-1080, 1997. (Pubitemid 27396495)
8. Agrawal V, Choi JH, Giacomini KM and Miller WL: Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase. Pharmacogenet Genom 20:611-618, 2010.
9. Fukushima-Uesaka H, Saito Y, Watanabe H, et al: Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population. Hum Mutat 23:100, 2004.
10. *18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects. Xenobiotica 37:315-327, 2007.
11. *1G polymorphism on metabolism of fentanyl in Chinese patients undergoing lower abdominal surgery. Clin Chim Acta 412:755-760, 2011.
12. *1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients. Eur J Clin Pharmacol 66:61-66, 2010.
13. Walter C and Lotsch J: Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. Pain 146:270-275, 2009.
14. Zhang W, Chang YZ, Kan QC, et al: Association of human micro-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients. Anaesthesia 65:130-135, 2010.
15. Fukuda K, Hayashida M, Ide S, et al: Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery. Pain 147:194-201, 2009.
16. Hayashida M, Nagashima M, Satoh Y, et al: Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. Pharmacogenomics 9:1605-1616, 2008.
17. Wong CA, McCarthy RJ, Blouin J and Landau R: Observational study of the effect of mu-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia. Int J Obstet Anesth 19:246-253, 2010.
18. Klepstad P, Fladvad T, Skorpen F, et al; European Palliative Care Research Collaborative (EPCRC); European Association for Palliative Care Research Network: Influence from genetic variability on opioid use for cancer pain: a Europeangenetic association study of 2294 cancer pain patients. Pain 152:1139-1145, 2011.
19. Landau R, Kern C, Columb MO, Smiley RM and Blouin JL: Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women. Pain 30:5-14, 2008.
20. Reyes-Gibby CC, Shete S, Rakvag T, et al: Exploring joint effects of gene and the clinical efficacy of morphine for cancer pain. Pain 130:25-30, 2007. (Pubitemid 46850782)
21. Kolesnikov Y, Gabovits B, Levin A, Voiko E and Veske A: Combined catechol. O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects. Anesth Analg 112:448-453, 2011.
22. Spielberger CD: Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, California, USA, 1983.
23. Zung WW: A self-rating depression scale. Arch Gen Psychiatry 12:63-70, 1965.
24. *1G on the fentanyl consumption for intravenous patient-controlled analgesia after total abdominal hysterectomy in Chinese Han population. J Clin Pharm Ther 37:153-156, 2012.
25. Tan PC, Hassan SK, Mohamad NA and Gan SH: Cytochrome P450 3A4 genetic polymorphisms and post-operative fentanyl requirements. J Clin Pharm Ther 37:100-104, 2012.